Chondromodulin-I and tenomodulin: A new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues

被引:71
作者
Shukunami, C
Oshima, Y
Hiraki, Y [1 ]
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Kyoto 6068507, Japan
[2] Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
anti-angiogenic resistance; chondromodulin-I; tenomodulin; cartilage; tendon and ligaments;
D O I
10.1016/j.bbrc.2005.05.133
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In tissues and/or organs of mesenchymal origin, the vasculature is usually well developed. However, there are certain hypovascular tissues that exhibit powerful anti-angiogenic resistance, implying the presence of tissue-type specific inhibitors of angiogenesis. Hyaline cartilage is one example, and several anti-angiogenic factors have been purified from cartilage. We previously identified chondromodulin-I (ChM-I) as a tissue-specific inhibitor of angiogenesis in fetal bovine cartilage. ChM-I is specifically expressed in the avascular regions of the growth-plate and cartilaginous bone rudiments in embryos. Recently, we cloned a novel type II transmembrane protein, tenomodulin (TeM), having a domain homologous to ChM-I at its C-terminus. TeM turned out to be expressed specifically in other hypovascular structures in the mesenchyme, such as the epimysium, tendon, and ligaments. In this overview, we discuss the structural characteristics of this class of anti-angiogenic molecules and their pathophysiological role in the control of vascularity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 49 条
[1]   Post-translational processing of bovine chondromodulin-I [J].
Azizan, A ;
Holaday, N ;
Neame, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :23632-23638
[2]   MAMMALIAN SUBTILISINS - THE LONG-SOUGHT DIBASIC PROCESSING ENDOPROTEASES [J].
BARR, PJ .
CELL, 1991, 66 (01) :1-3
[3]  
Benjamin M, 2000, INT REV CYTOL, V196, P85
[4]   PEDF: anti-angiogenic guardian of ocular function [J].
Bouck, N .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (07) :330-334
[5]   A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I [J].
Brandau, O ;
Meindl, A ;
Fässler, R ;
Aszódi, A .
DEVELOPMENTAL DYNAMICS, 2001, 221 (01) :72-80
[6]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[7]   A molecular analysis of matrix remodeling and angiogenesis during long bone development [J].
Colnot, CI ;
Helms, JA .
MECHANISMS OF DEVELOPMENT, 2001, 100 (02) :245-250
[8]   Tales of the cryptic: unveiling more angiogenesis inhibitors [J].
D'Amore, PA ;
Ng, YS .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (07) :313-315
[9]  
DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974
[10]   Pigment epithelium-derived factor: A potent inhibitor of angiogenesis [J].
Dawson, DW ;
Volpert, OV ;
Gillis, P ;
Crawford, SE ;
Xu, HJ ;
Benedict, W ;
Bouck, NP .
SCIENCE, 1999, 285 (5425) :245-248